address [clinicaltrials_resource:5c86f55f3592d29bea45a91fed1d5c7d]
Novartis Investigational Site [clinicaltrials_resource:3a7f669122c50efbaafdde7ba612530e][clinicaltrials_resource:5885ea9b2e247aaf99dc1a5fe48359d8]1 Site [clinicaltrials_resource:789eed9594ed9c635bcbd78c506db707]For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician [clinicaltrials_resource:796f8e77b0971ece8296ca4b7413292a]National Cancer Center Hospital East [clinicaltrials_resource:7b383d9709adef23fb0e3b5721988c3b]Novartis Investigative Site [clinicaltrials_resource:8515d458a9f3442ff58fd7110f5f9c94]Chiba Children's Hospital [clinicaltrials_resource:8d3dc83a795ce0c6cae82801176d90e3]Investigational Site [clinicaltrials_resource:a009fed716a97d06c368eaedd9ffb097]Research Site [clinicaltrials_resource:ab480e4123b1fd6ee3f467e75269fb31][clinicaltrials_resource:b9ea0ab4f15bc7c89c3aa3ba54eb9f54]Investigational site [clinicaltrials_resource:bb5bb3bd2ea68630b30a7f295b61231b]Pfizer Investigational Site [clinicaltrials_resource:bf59388b1b6cfcf8e5506f3376c268f5]For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. [clinicaltrials_resource:dd0b547e83fbf2643a808246a7513632]Clinic Tsudanuma [clinicaltrials_resource:ef5556fd0df6fcd8fa78bb396375b1f4]102 [clinicaltrials_resource:f041e4d48173627753466dd2a548da00][clinicaltrials_resource:f171aadd7d69432e260cb1f28cd28fcf]
address [clinicaltrials_vocabulary:address]
address [clinicaltrials_resource:5c86f55f3592d29bea45a91fed1d5c7d]
Bio2RDF identifier
5c86f55f3592d29bea45a91fed1d5c7d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5c86f55f3592d29bea45a91fed1d5c7d
city [clinicaltrials_vocabulary:city]
clinicaltrials_resource:4389869b3989f0097dc92e0afecd2e94
country [clinicaltrials_vocabulary:country]
clinicaltrials_resource:53a577bb3bc587b0c28ab808390f1c9b
identifier
clinicaltrials_resource:5c86f55f3592d29bea45a91fed1d5c7d
title
address
@en
type
label
address [clinicaltrials_resource:5c86f55f3592d29bea45a91fed1d5c7d]
@en